Appendix 3. References to abstracts included in study.

1. Aabom B, Kragstrup J, Vondeling H et al. Defining cancer patients as being in the terminal phase: who receives a formal diagnosis, and what are the effects? J Clin Oncol 2005, 23:7411-7416.

2. Addington-Hall JM, Karlsen S. A national survey of health professionals and volunteers working in voluntary hospice services in the UK. I. Attitudes to current issues affecting hospices and palliative care. Palliat Med 2005, 19:40-48.

3. Addington-Hall JM, Karlsen S. A national survey of health professionals and volunteers working in voluntary hospices in the UK. II. Staff and volunteers' experiences of working in hospices. Palliat Med 2005, 19:49-57.

4. Addington-Hall J, Altmann D. Which terminally ill cancer patients in the United Kingdom receive care from community specialist palliative care nurses? J Adv Nurs 2000, 32:799-806.

5. Agar M. Prospective study of predictors of the diagnosis of deliriuim or future development of the delirium: the association between serum anticholinergic levels and diagnosis or future development of delirium in palliative care patients with advanced cancer (ongoing). CareSearch Project Research Studies Register. [http://www.caresearch.com.au/home/Portals/CareSearch/Research%20Studies%20Register/0005.pdf]

6. Anderson H, Addington-Hall JM, Peake MD et al. Domiciliary chemotherapy with gemcitabine is safe and acceptable to advanced non-small-cell lung cancer patients: results of a feasibility study. Br J Cancer 2003, 89:2190-2196.

7. Anderson H, Ward C, Eardley A et al. The concerns of patients under palliative care and a heart failure clinic are not being met. Palliat Med 2001, 15:279-286.

8. Apolone G, Bertetto O, Caraceni A et al. Cancer Pain Outcome Research Study Group: Pain in cancer. An outcome research project to evaluate the epidemiology, the quality and the effects of pain treatment in cancer patients. Health Qual Life Outcomes 2006, 4:7.

9. Armes PJ, Higginson IJ. What constitutes high-quality HIV/AIDS palliative care? J Palliat Care 1999, 15:5-12.

10. Armes PJ, Addington-Hall JM. Perspectives on symptom control in patients receiving community palliative care. Palliat Med 2003, 17:608-615.

11. Arnau Solé G, Juanes Hernándiz MJ, Aguilar Martín C et al. Evolución de la anorexia en función del abordaje terapéutico en una Unidad de Cuidados Paliativos durante el año 2000. [Evolution of the anorexia according to the treatment in a Palliative Care Unit during the year 2000.] Sociedad Española de Cuidados Paliativos 2003, 10:66-71.[http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=139]

12. Ashby M, Fleming B, Wood M et al. Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatients. J Pain Symptom Manage 1997, 14:157-167.

13. Aste H, Munizzi F, Martines H et al. Esophageal dilation in malignant dysphagia. Cancer 1985, 56:2713-2715.

14. Ávila Tato R. Perfusión continua subcutánea: utilidad de la combinación de fármacos. [Continuous subcutaneous perfusion: usefulness of combined drugs.] Sociedad Española de Cuidados Paliativos 2005, 12:215-219. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=301]

15. Bagg J, Sweeney MP, Lewis MA et al. High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer. Palliat Med 2003, 17:477-481.

16. Balboni TA, Vanderwerker LC, Block SD et al. Religiousness and spiritual support among advanced cancer patients and associations with end-of-life treatment preferences and quality of life. J Clin Oncol 2007, 25:555-560.

17. Ball K, Sweeney MP, Baxter WP et al. Fluconazole sensitivities of Candida species isolated from the mouths of terminally ill cancer patients. Am J Hosp Palliat Care 1998, 15:315-319.

18. Barber MD, Fearon KC, Tisdale MJ et al. Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutr Cancer 2001, 40:118-124.

19. Barbera L, Paszat L Chartier, C. Indicators of poor quality end-of-life cancer care in Ontario. J Palliat Care 2006, 22:12-17.

20. Barnett TD, Rubins J. Placement of a permanent tunneled peritoneal drainage catheter for palliation of malignant ascites: a simplified percutaneous approach. J Vasc Interv Radiol 2002, 13:379-383.

21. Bausewein C, Fegg M, Radbruch L et al. Validation and clinical application of the german version of the palliative care outcome scale. J Pain Symptom Manage 2005, 30:51-62.

22. Bayés R, Limonero JT, Barreto P et al. Protocolo de una investigación multicéntrica sobre aspectos emocionales en enfermos en situación terminal. [A research system for emotional needs of terminal patients.] Sociedad Española de Cuidados Paliativos 2001, 8:71-79. http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=39

23. Bayés R, Limonero JT, Buendía B et al. Evaluación de la ansiedad ante la muerte. [Death anxiety assessment.] Sociedad Española de Cuidados Paliativos 1999, 6:140-143. http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=182

24. Bennett MI. Death rattle: an audit of hyoscine (scopolamine) use and review of management. J Pain Symptom Manage 1996, 12:229-233.

25. Bennett M, Cresswell H. Factors influencing constipation in advanced cancer patients: a prospective study of opioid dose, dantron dose and physical functioning. Palliat Med 2003, 17:418-422.

26. Benson M. Measuring Hope and Hopelessness in Cancer. CareSearch Project Research Studies Register. [http://www.caresearch.com.au/home/Portals/CareSearch/Research%20Studies%20Register/0016.pdf]

27. Benson M. Prospective Audit of Clinical Efficacy and Adverse Effects of Ketamine in the Management of Cancer Pain (1). CareSearch Project Research Studies Register. [http://www.caresearch.com.au/home/Portals/CareSearch/Research%20Studies%20Register/0023.pdf]

28. Benson M. Clinical Use, Efficacy and Adverse Effects of Ketamine in the Management of Cancer Pain at Peter MacCallum Cancer Care Centre- A Retrospective Chart Audit (2). CareSearch Project Research Studies Register.

[http://www.caresearch.com.au/home/Portals/CareSearch/Research%20Studies%20Register/0023.pdf]

29. Bentley A, Boyd K. Use of clinical pictures in the management of nausea and vomiting: a prospective audit. Palliat Med 2001, 15:247-253.

30. Bercovitch M, Waller A, Adunsky A. High dose morphine use in the hospice setting. A database survey of patient characteristics and effect on life expectancy. Cancer 1999, 86:871-877.

31. Bezjak A, Adam J, Barton R et al. Symptom response after palliative radiotherapy for patients with brain metastases. Eur J Cancer 2002, 38:487-496.

32. Bhatt ML, Mohani BK, Kumar L et al. Palliative treatment of advanced non small cell lung cancer with weekly fraction radiotherapy. Indian J Cancer 2000, 37:148-152.

33. Bieligk SC, Calvo BF, Coit DG. Peritoneovenous shunting for nongynecologic malignant ascites. Cancer 2001, 91:1247-1255.

34. Birch JF, White SA, Berry DP et al. A cost-benefit comparison of self-expanding metal stents and Atkinson tubes for the palliation of obstructing esophageal tumors. Dis Esophagus 1998, 11:172-176.

35. Brandt HE, Deliens L, Ooms ME et al. Symptoms, signs, problems, and diseases of terminally ill nursing home patients: a nationwide observational study in the Netherlands. Arch Intern Med 2005, 165:314-320.

36. Brandt HE, Deliens L, van der Steen JT et al. The last days of life of nursing home patients with and without dementia assessed with the palliative care outcome scale. Palliat Med 2005, 19:334-342.

37. Breitbart W, Rosenfeld B, Pessin H et al. Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA 2000, 284:2907-2911.

38. Brewster AE, Davidson SE, Makin WP et al. Intraluminal brachytherapy using the high dose rate microSelectron in the palliation of carcinoma of the oesophagus. Clin Oncol (R Coll Radiol) 1995, 7:102-105.

39. Bruera E, Suarez-Almazor M, Velasco A et al. The assessment of constipation in terminal cancer patients admitted to a palliative care

unit: a retrospective review. J Pain Symptom Manage 1994, 9:515-519.

40. Bruera E, Franco JJ, Maltoni M et al. Changing pattern of agitated impaired mental status in patients with advanced cancer: association with cognitive monitoring, hydration, and opioid rotation. J Pain Symptom Manage 1995, 10:287-291.

41. Burt J, Barclay S, Marshall N et al. Continuity within primary palliative care: an audit of general practice out-of-hours co-operatives. J Public Health (Oxf) 2004, 26:275-276.

42. Burt J, Shipman C, White P et al. Roles, service knowledge and priorities in the provision of palliative care: a postal survey of London GPs. Palliat Med 2006, 20:487-492.

43. Busquet Durán X, Morros Torné C, Busquet Mas C et al. La vía subcutánea en atención domiciliaria: un estudio prospective. [Subcutaneous route in home care: a prospective study]. Sociedad Española de Cuidados Paliativos 2001, 8:173-180. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=59]

44. Canal Sotelo J, Barallat Gimeno E, Vivas Brou C et al. Valoración de la implantación de un Programa Integral de Cuidados Paliativos. Visión retrospectiva 1995-1999. [Evaluation of the developement of a palliative car program. Review from 1995 to 1999.] Sociedad Española de Cuidados Paliativos 2004, 11:20-24.[http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=108]

45. Carmona Sáez T, Gómez Blázquez MA, Romero Mayoral P et al. Escala de Capacidad de Cuidados en Domicilio (ECCD): resultados preliminaries. [Home Care Capacity Scale (HCCS): preliminary results.] Sociedad Española de Cuidados Paliativos 2005, 12:197-203.[http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=298]

46. Catt, S, Blanchard M, Addington-Hall J et al. Older adults' attitudes to death, palliative treatment and hospice care. Palliat Med 2005, 19:402-410.

47. Cello JP, Grendell JH, Basuk P et al. Effect of octreotide on refractory AIDS-associated diarrhea. A prospective, multicenter clinical trial. Ann Intern Med 1991, 115:705-710.

48. Centeno C, Sánchez R, Vara F. Metadona en el tratamiento del dolor por cáncer: experiencia del Hospital Los Montalvos, Salamanca. [Methadone in the treatment of cancer pain: the experience of Hospital Los Montalvos, Salamanca.] Sociedad Española de Cuidados Paliativos 2004, 11:157-163. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=89]

49. Cerchietti L, Navigante A, Sauri A et al. Hypodermoclysis for control of dehydration in terminal-stage cancer. Int J Palliat Nurs 2000, 6:370-374.

50. Chambers JC. Should we screen hospice inpatients for orthostatic hypotension? Palliat Med 2005, 19:314-318.

51. Chambers JC. Does the use of a non-steroidal anti-inflammatory drug increase the likelihood of receiving a blood transfusion? Unpublished, personal communication.

52. Chambers JC. What should an out-of-hours service stock for emergency use in syringe drivers? Unpublished, personal communication.

53. Chambers JC. One hundred consecutive falls in a hospice inpatient unit: are newly prescribed psychotropics to blame? (ongoing) Unpublished, personal communication.

54. Chang E. Palliative Care Dementia Interface: Enhancing Community Capacity. CareSearch Project Research Studies Register [http://www.caresearch.com.au/Home/Portals/CareSearch/Research%20Studies%20Register/0032.pdf]

55. Chang E. Decision making frameworks in advanced dementia: links to improved care. CareSearch Project Research Studies Register [http://www.caresearch.com.au/Home/Portals/CareSearch/Research%20Studies%20Register/0034.pdf]

56. Chang E. Evaluation of an information booklet for family carers of people with dementia. CareSearch Project Research Studies Register [http://www.caresearch.com.au/Home/Portals/CareSearch/Research%20Studies%20Register/0033.pdf]

57. Chapman, Y (contact investigator Lee, S). A very public death - exploring the needs of a person dying of mesothelioma or asbestos related lung disease

http://www.caresearch.com.au/Home/Portals/CareSearch/Research%20Studies%20Register/0037.pdf

58. Chater S, Viola R, Paterson J et al. Sedation for intractable distress in the dying - a survey of experts. Palliat Med 1998, 12:255-269.

59. Chen LK, Chou YC, Hsu PS et al. Antibiotic prescription for fever episodes in hospice patients. Support Care Cancer 2002, 10:538-541.

60. Cherlin E, Fried T, Prigerson HG et al. Communication between physicians and family caregivers about care at the end of life: when do discussions occur and what is said? J Palliat Med 2005, 8:1176-1185.

61. Chiu TY, Hu WY, Lue BH et al. Sedation for refractory symptoms of terminal cancer patients in Taiwan. J Pain Symptom Manage 2001, 21:467-472.

62. Chochinov HM, Wilson KG, Enns M et al. Prevalence of depression in the terminally ill: effects of diagnostic criteria and symptom threshold judgments. Am J Psychiatry 1994, 151:537-540.

63. Chochinov HM, Wilson KG, Enns M et al. Depression, Hopelessness, and suicidal ideation in the terminally ill. Psychosomatics 1998, 39:366-370.

64. Chochinov HM, Wilson KG, Enns M et al. Desire for death in the terminally ill. Am J Psychiatry 1995, 152:1185-1191.

65. Chong K, Olson EM, Banc TE et al. Types and rate of implementation of palliative care team recommendations for care of hospitalized veterans. J Palliat Med 2004, 7:784-790.

66. Chow E, Wong R, Hruby G et al. Prospective patient-based assessment of effectiveness of palliative radiotherapy for bone metastases. Radiother Oncol 2001, 61:77-82.

67. Christakis NA, Escarce JJ. Survival of Medicare patients after enrollment in hospice programs. N Engl J Med 1996, 335:172-178. 68. Christakis NA, Iwashyna TJ. Impact of individual and market factors on the timing of initiation of hospice terminal care. Med Care 2000, 38:528-541.

69. Christakis NA, Iwashyna TJ. The health impact of health care on families: a matched cohort study of hospice use by decedents and

mortality outcomes in surviving, widowed spouses. Soc Sci Med 2003, 57:465-475.

70. Christakis NA, Lamont EB. Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study. BMJ 2000, 320:469-472.

71. Christakis NA. Timing of referral of terminally ill patients to an outpatient hospice. J Gen Intern Med 1994, 9:314-320.

72. Clare C, Royle D, Saharia K et al. Painful bone metastases: a prospective observational cohort study. Palliat Med 2005, 19:521-525.

73. Clayton J, Fardell B, Hutton-Potts J et al. Parenteral antibiotics in a palliative care unit: prospective analysis of current practice. Palliat Med 2003, 17:44-48.

74. Cohen LM, Germain M, Poppel DM et al. Dialysis discontinuation and palliative care. Am J Kidney Dis 2000, 36:140-144.

75. Collete N. Expresión plástica del dolor por el paciente. [Drawing representation of pain made by patients.] Sociedad Española de Cuidados Paliativos 2002, 9:141-147. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=86]

76. Collin E, Poulain P, Gauvain-Piquard A et al. Is disease progression the major factor in morphine 'tolerance' in cancer pain treatment? Pain 1993, 55:319-326.

77. Costantini M, Toscani F, Gallucci M et al. Italian Cooperative Research Group on Palliative Medicine: Terminal cancer patients and timing of referral to palliative care: a multicenter prospective cohort study. J Pain Symptom Manage 1999, 18:243-252.

78. Costantini M, Higginson IJ, Boni L et al. Effect of a palliative home care team on hospital admissions among patients with advanced cancer. Palliat Med 2003, 17:315-321.

79. Crawford J, Demetri GD, Gabrilove JL et al. Clinical benefits of epoetin alfa therapy in patients with lung cancer. Clin Lung Cancer 2002, 3:180-190.

80. Crawford G. Objective Assessment of the trajectory of the course of illness for end of life non-cancer related diseases - biological, social and environmental determinants (ongoing). CareSearch Project

Research Studies Register http://www.caresearch.com.au/home/Portals/CareSearch/Research%20Studies%20Register/0009.pdf

81. Dafermou A, Colamussi P, Giganti M et al. A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer. Eur J Nucl Med 2001, 28:788-798.

82. Dauphin S, Katz S, el Tamer M et al. Chemotherapy is a safe and effective initial therapy for infected malignant breast and chest wall ulcers. J Surg Oncol 1997, 66:186-188.

83. Davies E, Clarke C, Hopkins A. Malignant cerebral glioma--I: Survival, disability, and morbidity after radiotherapy. BMJ 1996, 313:1507-1512.

84. Davies E, Clarke C, Hopkins A. Malignant cerebral glioma--II: Perspectives of patients and relatives on the value of radiotherapy. BMJ 1996, 313:1512-1516.

85. Davis J. Phase II study into olanzepine in anorexia cachexia. (existence suggested by another email respondent).

86. Detmar SB, Muller MJ, Wever LD et al. The patient-physician relationship. Patient-physician communication during outpatient palliative treatment visits: an observational study. JAMA 2001, 285:1351-1357.

87. Deus i Yela J, Villar-Fernández JL, Salas-Cortés M et al. Estudio piloto prospectivo del deterioro cognitivo en pacientes oncológicos paliativos ambulatorios. [Prospective pilot study of cognitive impairment in palliative oncologic outpatients.] Sociedad Española de Cuidados Paliativos 2005, 12:6-11.[http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=257]

88. Douglas HR, Normand CE, Higginson IJ et al. A new approach to eliciting patients' preferences for palliative day care: the choice experiment method. J Pain Symptom Manage 2005, 29:435-445.

89. Douglas HR, Higginson IJ, Myers K et al. Assessing structure, process and outcome in palliative day care: a pilot study for a multicentre trial. Health Soc Care Community 2000, 8:336-344.

90. Douglas HR, Normand CE, Higginson IJ et al. Palliative Day Care Project Group: Palliative day care: what does it cost to run a centre and does attendance affect use of other services? Palliat Med 2003, 17:628-637.

91. Dunckley M, Aspinal F, Addington-Hall JM et al. A research study to identify facilitators and barriers to outcome measure implementation. Int J Palliat Nurs 2005, 11:218-225.

92. Dunckley M, Hughes R, Addington-Hall J et al. Language translation of outcome measurement tools: views of health professionals. Int J Palliat Nurs 2003, 9:49-55.

93. Edmonds P, Davies C. Experience of the use of subcutaneous ketamine in patients with cancer-relatedneuropathic pain. Proceedings of the European Association for Palliative Care Conference, London. 1997. [http://www.eapcnet.org/about/about.html]

94. Edmonds P, Higginson I, Altmann D et al. Is the presence of dyspnoea a risk factor for morbidity in cancer patients? J Pain Symptom Manage 2000, 19:15-22.

95. Edmonds P, Karlsen S, Khan S et al. A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med 2001, 15:287-295.

96. Eickhoff A, Hartmann D, Jakobs R et al. [Comparison of 3 types of covered self-expanding metal stents for the palliation of malignant dysphagia: results from the prospective Ludwigshafen Esophageal Cancer Register] Z Gastroenterol 2005, 43:1113-1121.

97. Elkington H, White P, Addington-Hall J et al. The last year of life of COPD: a qualitative study of symptoms and services. Respir Med 2004, 98:439-445.

98. Ell C, Hochberger J, May A et al. Coated and uncoated self-expanding metal stents for malignant stenosis in the upper GI tract: preliminary clinical experiences with Wallstents. Am J Gastroenterol 1994, 89:1496-1500.

99. Eslava Gurrea E, Viguria Arrieta JM, Rocafort Gil J et al. Sedación con midazolam. Eficacia de un protocolo de tratamiento en pacientes terminales con síntomas no controlables con otros medios. [Sedation with midazolam. Effectiveness of protocol for tratment in terminal pattient with non controllable symptoms by other means.] Sociedad Española de Cuidados Paliativos 2000, 7:2-5.

[http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=67]

100. Eve A, Higginson IJ. Minimum dataset activity for hospice and hospital palliative care services in the UK 1997/98. Palliat Med 2000, 14:395-404.

101. Fainsinger RL, Waller A, Bercovici M et al. A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med 2000, 14:257-265.

102. Fainsinger RL, De Moissac D, Mancini I et al. Sedation for delirium and other symptoms in terminally ill patients in Edmonton. J Palliat Care 2000, 16:5-10.

103. Fainsinger RL, Landman W, Hoskings M et al. Sedation for uncontrolled symptoms in a South African hospice. J Pain Symptom Manage 1998, 16:145-152.

104. Fainsinger RL, MacEachern T, Miller MJ et al. The use of hypodermoclysis for rehydration in terminally ill cancer patients. J Pain Symptom Manage 1994, 9:298-302.

105. Farquhar MC, Barclay SI, Earl H et al. Barriers to effective communication across the primary/secondary interface: examples from the ovarian cancer patient journey (a qualitative study). Eur J Cancer Care (Engl) 2005, 14:359-366.

106. Fernández González MJ, Roces Camino JR, Valdés Gómez C et al. Equipo de soporte de atención domiciliaria. Resumen de la actividad realizada en los dieciséis primeros meses de funcionamiento del ESAD. Área Sanitaria V-Gijón (1 de octubre, 2000 a 31 de enero, 2002). [Analysis of the activity of a Home Care Support Team.] Sociedad Española de Cuidados Paliativos 2003, 10:72-77. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=140]

107. Fleming J. Assessment of Post-operative Pain Management in Patient Undergoing Surgery in a Cancer Hospital: An Audit using the VQC Pain Assessment Tool-kit (ongoing). CareSearch Project Research Studies Register [http://www.caresearch.com.au/home/Portals/CareSearch/Research%20Studies%20Register/0025.pdf]

108. Fleming, J (ongoing). Retrospective and Prospective Audit of Gabapentin and Pre-Gablin Prescribing for Neuropathic Pain in a

Major Cancer Hospital. CareSearch Project Research Studies Register [http://www.caresearch.com.au/home/Portals/CareSearch/Research%20Studies%20Register/0024.pdf]

109. Fombuena Moreno M, Espinar Cid MV. Tratamiento antibiótico en pacientes oncológicos terminales. Experiencia de una Unidad de Cuidados Paliativos. [Antibiotic treatment in terminally ill oncologic patients. A Palliative Care Unit experience.] Sociedad Española de Cuidados Paliativos 2005, 12:152-158. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=278]

110. Fombuena Moreno M, Espinar Cid V, García Gasc P et al. Fiebre en la última semana de vida de pacientes oncológicos terminals. [Fever in the last days of life of terminally ill oncologic patients.] Sociedad Española de Cuidados Paliativos 2002, 9:112-115. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=216]

111. Fombuena Moreno M, Madrid Juan F, García Gascó P et al. Infección y cuidados paliativos oncológicos. Estudio de prevalencia. [Infection and oncologic palliative care. Study of prevalence.] Sociedad Española de Cuidados Paliativos 2000, 7:135-139. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=195]

112. Fombuena Moreno M, Espinar Cid MV, Tolosa Martínez N et al. Incidencia de infección nosocomial y sintomatología asociada en pacientes oncológicos terminals. [Incidence of nosocomial infections and symptoms associated to oncological terminal patients.] Sociedad Española de Cuidados Paliativos 2004, 11:83-88. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=97]

113. Freeman L, Caserta M, Lund D et al. Music thanatology: prescriptive harp music as palliative care for the dying patient. Am J Hosp Palliat Care 2006, 23:100-104.

114. Fridriksdottir N, Sigurdardottir V, Gunnarsdottir S. Important needs of families in acute and palliative care settings assessed with the family inventory of needs. Palliat Med 2006, 20:425-432.

115. Galvin J. An audit of pressure ulcer incidence in a palliative care setting. Int J Palliat Nurs 2002, 8:214-221.

116. García Cantero E, Prieto Redondo L, Pérez Hernández F et al. Optimización del uso de morfina como objetivo de un equipo de soporte de atención domiciliaria en un área de salud. [Improvement in morphine use as an aim of a home care team of Primary Care in a health area.] Sociedad Española de Cuidados Paliativos 2003, 10:202-207. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=133]

117. Garde Orbaiz C, Goenaga Sánchez MA, Millet Sanpedro M et al. Hospitalización a domicilio en la atención al paciente en situación terminal. [Hospital at home units and terminal patients.] Sociedad Española de Cuidados Paliativos 2003, 10:127-132. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=144]

118. Gauvain-Piquard A, Rodary C, Rezvani A et al. The development of the DEGR(R): A scale to assess pain in young children with cancer. Eur J Pain 1999, 3:165-176.

119. Gebbia V, Di Marco P, Citarrella P. Systemic chemotherapy in elderly patients with locally advanced and/or inoperable squamous cell carcinoma of the head and neck: impact of anaemia and role of recombinant human erythropoietin. Crit Rev Oncol Hematol 2003, 48:S49-55.

120. Gibbs LM, Ellershaw JE, Williams MD. Caring for patients with HIV disease: the experience of a generic hospice. AIDS Care 1997, 9:601-607.

121. Giris A. Evaluation of the Palliative Care Needs Assessment Intervention (ongoing). CareSearch Project Research Studies Register [http://www.caresearch.com.au/home/Portals/CareSearch/Research%20Studies%20Register/0021.pdf]

122. Gisbert A, Gómez F, Bruera E. Valoración global del control de síntomas al final de la vida. [Global assessment of symptom control at the end of life.] Sociedad Española de Cuidados Paliativos 2004, 11:79-82.[http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=102]

123. Gisbert Aguilar A, Pascual López A. Manifestaciones clínicas y biológicas de la deshidratación en el enfermo en fase terminal. [Clinical and biological manifestations of dehydration in the terminal patient.] Sociedad Española de Cuidados Paliativos 2000, 7:129-134.

[http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=194]

124. Glare P. Cytokines in anorexia cachexia (ongoing). [suggested by another email respondent].

125. Gleeson C, Spencer D. Blood transfusion and its benefits in palliative care. Palliat Med 1995, 9:307-313.

126. Glimelius B, Linné T, Hoffman K et al. Epoetin beta in the treatment of anemia in patients with advanced gastrointestinal cancer. J Clin Oncol 1998, 16:434-440.

127. Gómez-Batiste X, Viladiu P, Fontanals MªD et al. Morir de cáncer en Cataluña: estudio poblacional sobre. [Cancer death in Catalonia: population study about the last month of life in cancer patients (1993-94).] Sociedad Española de Cuidados Paliativos 2001, 8:134-137. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=53]

128. González Barón M, Lacasta Reverte MA, Ordóñez Gallego A. Elaboración de un instrumento que permita identificar y aliviar el sufrimiento. Estudio preliminary. [Development of an instrument that allows to identify and alleviate the suffering. Preliminary study.] Sociedad Española de Cuidados Paliativos 2003, 10:191-201.[http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=132]

129. Goodwin DM, Higginson IJ, Myers K et al. Effectiveness of palliative day care in improving pain, symptom control, and quality of life. J Pain Symptom Manage 2003, 25:202-212.

130. Goodwin DM, Higginson IJ, Myers K et al. What is palliative day care? A patient perspective of five UK services. Support Care Cancer 2002, 10:556-562.

131. Grande GE, McKerral A, Addington-Hall JM et al. Place of death and use of health services in the last year of life. J Palliat Care 2003, 19:263-270.

132. Grocott P. The palliative management of fungating malignant wounds. J Wound Care 2000, 9:4-9.

133. Gysels M, Hughes R, Aspinal F et al. What methods do stakeholders prefer for feeding back performance data: a qualitative study in palliative care. Int J Qual Health Care 2004, 16:375-381.

134. Hall P, Schroder C, Weaver L. The last 48 hours of life in long-term care: a focused chart audit. J Am Geriatr Soc 2002, 50:501-506.

135. Hanks GW, Trueman T, Twycross RG. Corticosteroids in terminal cancer--a prospective analysis of current practice. Postgrad Med J 1983, 59:702-706. 136. Harding R, Higginson IJ, Leam C et al. Evaluation of a short-term group intervention for informal carers of patients attending a home palliative care service. J Pain Symptom Manage 2004, 27:396-408.

137. Harding R, Higginson IJ, Donaldson N. The relationship between patient characteristics and carer psychological status in home palliative cancer care. Support Care Cancer 2003, 11:638-643.

138. Harding R, Leam C. Clinical notes for informal carers in palliative care: recommendations from a random patient file audit. Palliat Med 2005, 19:639-642.

139. Harding R, Stewart K, Marconi K et al. Current HIV/AIDS end-of-life care in sub-Saharan Africa: a survey of models, services, challenges and priorities. BMC Public Health 2003, 3:33.

140. Hardy JR, Rees E, Ling J et al. One hundred and six consecutive patients started on glucocorticosteroid A prospective survey of the use of dexamethasone on a palliative care unit. Palliat Med 2001, 15:3-8.

141. Hately J, Laurence V, Scott A et al. Breathlessness clinics within specialist palliative care settings can improve the quality of life and functional capacity of patients with lung cancer. Palliat Med 2003, 17:410-417.

142. Henriksen H, Riis J, Christophersen B et al. [Distress symptoms in hospice patients]. Ugeskr Laeger 1997, 159:6992-6996.

143. Hermida Porto L, Blanco Rodríguez R, Prego Domínguez J. Tratamiento del dolor en pacientes paliativos: asignatura pendiente en la mayoría de los servicios intra y extrahospitalarios. [Treatment of the pain in palliative patients: pending subset in most services intra and extrahospital]. Sociedad Española de Cuidados Paliativos 2005, 12:74-75.[http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=267]

144. Hernansanz S, Gutiérrez C, Flores LA et al. Experiencia en paracentesis en el domicilio como paliación de la ascitis de origen tumoral. [Experience with in-home paracentesis for the palliation of tumoral ascites]. Sociedad Española de Cuidados Paliativos 2005, 12:220-222.[http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=302]

145. Hernansanz S, Gutiérrez C, Rubiales AS et al. Ausencia de diagnóstico histológico en una Unidad de Cuidados Paliativos. [Absence of histiological diagnosis in Palliative Care Units.] Sociedad Española de Cuidados Paliativos 2002, 9:173-177.[http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=231]

146. Heyse-Moore L, Beynon T, Ross V. Does spirometry predict dyspnoea in advanced cancer? Palliat Med 2000, 14:189-195.

147. Higginson IJ, Astin P, Dolan S. Where do cancer patients die? Ten-year trends in the place of death of cancer patients in England. Palliat Med 1998, 12:353-363.

148. Higginson IJ, Jarman B, Astin P et al. Do social factors affect where patients die: an analysis of 10 years of cancer deaths in England. J Public Health Med 1999, 21:22-28.

149. Higginson IJ, Costantini M. Accuracy of prognosis estimates by four palliative care teams: a prospective cohort study. BMC Palliat Care 2002, 1:1.

150. Higginson IJ, Costantini M. Communication in end-of-life cancer care: a comparison of team assessments in three European countries. J Clin Oncol 2002, 20:3674-3682.

151. Higginson IJ, Donaldson N. Relationship between three palliative care outcome scales. Health Qual Life Outcomes 2004, 2:68.

152. Higginson IJ, Hearn J, Myers K et al. Palliative day care: what do services do? Palliative Day Care Project Group. Palliat Med 2000, 14:277-286.

153. Higginson IJ, Hearn J. A multicenter evaluation of cancer pain control by palliative care teams. J Pain Symptom Manage 1997, 14:29-35.

154. Higginson IJ, Koffman J. Attitudes to timeliness of death and euthanasia among first generation black Caribbean and white patients and their families living in the United Kingdom. J Palliat Med 2003, 6:245-249.

155. Higginson IJ, Thompson M. Children and young people who die from cancer: epidemiology and place of death in England (1995-9). BMJ 2003, 327:478-479.

156. Higginson IJ, Wilkinson S. Marie Curie nurses: enabling patients with cancer to die at home. Br J Community Nurs 2002, 7:240-244.

157. Hodgson C, Higginson I, McDonnell M et al. Family anxiety in advanced cancer: a multicentre prospective study in Ireland. Br J Cancer 1997, 76:1211-1214.

158. Holzapfel L, Demingeon G, Piralla B et al. A four-step protocol for limitation of treatment in terminal care. An observational study in 475 intensive care unit patients. Intensive Care Med 2002, 28:1309-1315.

159. Hughes R, Aspinal F, Addington-Hall J et al. Professionals' views and experiences of using outcome measures in palliative care. Int J Palliat Nurs 2003, 9:234-238.

160. Hughes R, Saleem T, Addington-Hall J. Towards a culturally acceptable end-of-life survey questionnaire: a Bengali translation of VOICES. Int J Palliat Nurs 2005, 11:116-123.

161. Hughes RA, Sinha A, Higginson I et al. Living with motor neurone disease: lives, experiences of services and suggestions for change. Health Soc Care Community 2005, 13:64-74.

162. Hunt A, Goldman A, Devine T et al. FEN-GBR-14 Study Group: Transdermal fentanyl for pain relief in a paediatric palliative care population. Palliat Med 2001, 15:405-412.

163. Iwashyna TJ, Zhang JX, Christakis NA. Disease-specific patterns of hospice and related healthcare use in an incidence cohort of seriously ill elderly patients. J Palliat Med 2002, 5:531-538.

164. Iwashyna TJ, Chang VW, Zhang JX et al. The lack of effect of market structure on hospice use. Health Serv Res 2002, 37:1531-1551.

165. Johnstone PA, Polston GR, Niemtzow RC et al. Integration of acupuncture into the oncology clinic. Palliat Med 2002, 16:235-239.

166. Kadan-Lottick NS, Vanderwerker LC, Block SD et al. Psychiatric disorders and mental health service use in patients with advanced cancer: a report from the coping with cancer study. Cancer 2005, 104:2872-2881.

167. Kahl S, Trivisonno F. Valoración clínica del estado de salud de pacientes con metástasis cerebrales tratados con radioterapia paliativa. (Clinical valuation of health status of patients with brain metastasis treated with palliative radiotherapy). Sociedad Española de Cuidados Paliativos 2003, 10:9-13.[http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=119]

168. Karus D, Raveis VH, Marconi K et al. Service needs of patients with advanced HIV disease: a comparison of client and staff reports at three palliative care projects. AIDS Patient Care STDS 2004, 18:145-158.

169. Karus D, Raveis VH, Marconi K et al. Mental health status of clients from three HIV/AIDS palliative care projects. Palliat Support Care 2004, 2:125-138.

170. Khoo D, Hall E, Motson R et al. Palliation of malignant intestinal obstruction using octreotide. Eur J Cancer 1994, 30A:28-30.

171. Klepstad P, Hilton P, Moen J et al. Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study. BMC Clin Pharmacol 2004, 4:7.

172. Koffman J, Higginson I, Naysmith A et al. Hospice at home--a new service for patients with advanced HIV/AIDS: a pilot evaluation of referrals and outcomes. Br J Gen Pract 1996, 46:539–540.

173. Koffman J, Donaldson N, Hotopf M et al. Does ethnicity matter? Bereavement outcomes in two ethnic groups living in the United Kingdom. Palliat Support Care 2005, 3:183-190.

174. Koffman J, Higginson IJ, Donaldson N. Symptom severity in advanced cancer, assessed in two ethnic groups by interviews with bereaved family members and friends. J R Soc Med 2003, 96:10-16.

175. Koffman J, Higginson IJ. Assessing the effectiveness and acceptability of interprofessional palliative care education. J Palliat Care 2005, 21:262-269.

176. Koffman J, Higginson IJ. Dying to be home? Preferred location of death of first-generation black Caribbean and native-born white patients in the United Kingdom. J Palliat Med 2004, 7:628-636.

177. Koffman J, Higginson IJ. Accounts of carers' satisfaction with health care at the end of life: a comparison of first generation black Caribbeans and white patients with advanced disease. Palliat Med 2001, 15:337-345.

178. Kuin A, Deliens L, van Zuylen L et al. Spiritual issues in palliative care consultations in the Netherlands. Palliat Med 2006, 20:585-592.

179. Labori KJ, Hjermstad MJ, Wester T et al. Symptom profiles and palliative care in advanced pancreatic cancer: a prospective study. Support Care Cancer 2006, 14:1126-1133.

180. Lamont EB, Christakis NA. Prognostic disclosure to patients with cancer near the end of life. Ann Intern Med 2001, 134:1096-1105.

181. Lamont EB, Christakis NA. Physician factors in the timing of cancer patient referral to hospice palliative care. Cancer 2002, 94:2733-2737.

182. Lamy O, Jenzer-Closuit A, Burckhardt P. Hypercalcaemia of malignancy: an undiagnosed and undertreated disease. J Intern Med 2001, 250:73-79.

183. Lawlor PG, Gagnon B, Mancini IL et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med 2000, 160:786-794.

184. Le Fevre P, Devereux J, Smith S et al. Screening for psychiatric illness in the palliative care inpatient setting: a comparison between the Hospital Anxiety and Depression Scale and the General Health Questionnaire-12. Palliat Med 1999, 13:399-407.

185. Lee MA, Leng ME, Tiernan EJ. Retrospective study of the use of hydromorphone in palliative care patients with normal and abnormal urea and creatinine. Palliat Med 2001, 15:26-34.

186. Lloyd-Williams M, Friedman T, Rudd N. An analysis of the validity of the Hospital Anxiety and Depression scale as a screening tool in patients with advanced metastatic cancer. J Pain Symptom Manage 2001, 22:990-996.

187. Lloyd-Williams M, Friedman T, Rudd N. A survey of antidepressant prescribing in the terminally ill. Palliat Med 1999, 13:243-248.

188. Lloyd-Williams M, Riddleston H. The stability of depression scores in patients who are receiving palliative care. J Pain Symptom Manage 2002, 24:593-597.

189. Lloyd-Williams M. Is it appropriate to screen palliative care patients for depression? Am J Hosp Palliat Care 2002, 19:112-114.

190. Lloyd-Williams M. How common are thoughts of self-harm in a UK palliative care population? Support Care Cancer 2002, 10:422-424.

191. Lobb EA. A study to assess the grief experienced by registered nurses and care aides who work in community palliative care and to identify suitable strategies for support. CareSearch Project Research Studies Register [http://www.caresearch.com.au/home/Portals/CareSearch/Research%20Studies%20Register/0007.pdf]

192. Lock A, Higginson I. Patterns and predictors of place of cancer death for the oldest old. BMC Palliat Care 2005, 4:6.

193. Logie DE, Harding R. An evaluation of a morphine public health programme for cancer and AIDS pain relief in Sub-Saharan Africa. BMC Public Health 2005, 5:82.

194. London MR, McSkimming S, Drew N et al. Evaluation of a Comprehensive, Adaptable, Life- Affirming, Longitudinal (CALL) palliative care project. J Palliat Med 2005, 8:1214-1225.

195. Lowton K. Parents and partners: lay carers' perceptions of their role in the treatment and care of adults with cystic fibrosis. J Adv Nurs 2002, 39:174-181.

196. Lundström S, Fürst CJ. Symptoms in advanced cancer: relationship to endogenous cortisol levels. Palliat Med 2003, 17:503-508.

197. Lundström SH, Fürst CJ. The use of corticosteroids in Swedish palliative care. Acta Oncol 2006, 45:430-437.

198. Lyall RA, Donaldson N, Fleming T et al. A prospective study of quality of life in ALS patients treated with noninvasive ventilation. Neurology 2001, 57:153-156.

199. Lyall RA, Donaldson N, Polkey MI et al. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain 2001, 124:2000-2013.

200. Maguire P, Walsh S, Jeacock J et al. Physical and psychological needs of patients dying from colo-rectal cancer. Palliat Med 1999, 13:45-50.

201. Maloney CM, Kesner RK, Klein G et al. The rectal administration of MS Contin: clinical implications of use in end stage cancer. Am J Hosp Care 1989, 6:34-35.

202. Mandler RN, Anderson FA Jr, Miller RG et al. ALS C.A.R.E. Study Group: The ALS Patient Care Database: insights into end-of-life care in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2001, 2:203-208.

203. Mang TS, Allison R, Hewson G et al. A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer. Cancer J Sci Am 1998, 4:378-384.

204. Martin SC, Gagnon DD, Zhang L et al. Cost-utility analysis of survival with epoetin-alfa versus placebo in stage IV breast cancer. Pharmacoeconomics 2003, 21:1153-1169.

205. Martín Aspas A, Benítez Macías JF, Benítez Rodríguez E et al. Relación entre factores precipitantes y mortalidad en el delirio agitado en Cuidados Paliativos. [Relation of precipitating factors and mortality in agitated delirium of Palliative Care patients]. Sociedad Española de Cuidados Paliativos 2005, 12:147-151. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=277]

206. Martín Morales AP, Domínguez Castillejos G, Rodríguez D et al. Cuidados Paliativos en pueblos indígenas mexicanos. [Palliative Care in the Mexican ethnic group]. Sociedad Española de Cuidados Paliativos 2004, 11:220-230. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=287]

207. Martínez Fernández AM, Casero Fernández-Montes A. Las 24 últimas horas de vida del paciente oncológico tratado por una Unidad de Cuidados Paliativos Domiciliaria: un estudio piloto. [The oncology patient latest 24 hours living treated by a Domiciliary Care Unit]. Sociedad Española de Cuidados Paliativos 2000, 7:124-128. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=193]

208. Martínez M, Nekolaichuk CH, Bruera E. La frecuencia del dolor y su relación con otros síntomas psicosociales en pacientes con cáncer terminal. [The frequency of pain and its relationship to other psychosocial symptom in terminally ill cancer patients]. Sociedad Española de Cuidados Paliativos 1999;6(3):116-120. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=174]

209. McCann RM, Hall WJ, Groth-Juncker A: Comfort care for terminally ill patients. The appropriate use of nutrition and hydration. JAMA 1994, 272:1263-1266.

210. McCarthy M, Lay M, Addington-Hall J. Dying from heart disease. J R Coll Physicians Lond 1996, 30:325-328.

211. McDermott OD, Prigerson HG, Reynolds CF 3rd et al. Sleep in the wake of complicated grief symptoms: an exploratory study. Biol Psychiatry 1997, 41:710-716.

212. McGrath P, Holewa H. Missed opportunities: nursing insights on end-of-life care for haematology patients. Int J Nurs Pract 2006, 12:295-301.

213. McGrath P. IPP-SHR and Redland Hospital Collaboration - Ethical decision making in a health care setting including findings on end of life care (ongoing). CareSearch Project Research Studies Register [http://www.caresearch.com.au/home/Portals/CareSearch/Research%20Studies%20Register/0010.pdf]

214. McGrath P. The development of a model of care for haematology and palliative care (ongoing). CareSearch Project Research Studies Register [http://www.caresearch.com.au/home/Portals/CareSearch/Research%20Studies%20Register/0011.pdf]

215. McNamara P, Sharma K. Surgery or palliation for hip fractures in patients with advanced malignancy? Age Ageing 1997, 26:471-474.

216. McNamara P, Minton M, Twycross RG. Use of midazolam in palliative care. Palliat Med 1991, 5:244-249.

217. McPherson CJ, Addington-Hall JM. How do proxies' perceptions of patients' pain, anxiety, and depression change during the bereavement period? J Palliat Care 2004, 20:12-19.

218. Mercadante S, Casuccio A, Fulfaro F et al. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. J Clin Oncol 2001, 19:2898-2904.

219. Mercadante S, Casuccio A, Fulfaro F. The course of symptom frequency and intensity in advanced cancer patients followed at home. J Pain Symptom Manage 2000, 20:104-112.

220. Mercadante S, Fulfaro F, Casuccio A. The impact of home palliative care on symptoms in advanced cancer patients. Support Care Cancer 2000, 8:307-310.

221. Mercadante S, Fulfaro F, Casuccio A. The use of corticosteroids in home palliative care. Support Care Cancer 2001, 9:386-389.

222. Meuser T, Pietruck C, Radbruch L et al. Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain 2001, 93:247-257.

223. Miccinesi G, Paci E, Toscani F et al. [Quality of life at the end of life. Analysis of the quality of life of oncologic patients treated with palliative care. Results of a multicenter observational study (staging)] Epidemiol Prev 1999, 23:333-345.

224. Miller G, Boman J, Shrier I et al. Small-bowel obstruction secondary to malignant disease: an 11-year audit. Can J Surg 2000, 43:353-358.

225. Mitchell SL. NIA R01AG024091 The CASCADE Study: End-of-Life in Advanced Dementia 09/24/2004-09/29/2009 (ongoing). [Associated publication: Mitchell SL, Kiely DK, Jones RN, Prigerson H, Volicer L, Teno JM. Advanced dementia research in the nursing home: the CASCADE study. Alzheimer Dis Assoc Disord. 2006 Jul-Sep;20(3):166-75.]

226. Molina Linde JM, Romero Cotelo J, Romero Rodríguez Y et al. Alteraciones emocionales en el cuidador del enfermo oncológico terminal. [Emotional dysfunctions in terminal cancer patients’ caregiver]. Sociedad Española de Cuidados Paliativos 2005, 12:83-87. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=269]

227. Molina Linde JM, Romero Cotelo J, Romero Rodríguez Y et al. Pacientes mayores oncológicos incluidos en un programa de Cuidados Paliativos. [Oncological older patients included in a program of Palliative Care]. Sociedad Española de Cuidados Paliativos 2005, 12:88-91. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=270]

228. Monti M, Castellani L, Berlusconi A et al. Use of red blood cell transfusions in terminally ill cancer patients admitted to a palliative care unit. J Pain Symptom Manage 1996, 12:18-22.

229. Morales E, Lloréns R, Folgado J et al. Infección de los dispositivos i.v. en pacientes sida en fase terminal del Programa de Hospitalización Domiciliaria de Cruz Roja de Valencia. [Infection of intravenous devices in terminal aids patient treated at Home by a Cruz Roja Programm in Valencia]. Sociedad Española de Cuidados Paliativos 2000, 7:45-48. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=76]

230. Morgan S, Evans N. A small observational study of the longevity of syringe driver sites in palliative care. Int J Palliat Nurs 2004, 10:405-412.

231. Morita T, Tei Y, Inoue S et al. Fluid status of terminally ill cancer patients with intestinal obstruction: an exploratory observational study. Support Care Cancer 2002, 10:474-479.

232. Morita T, Chinone Y, Ikenaga M, Miyoshi M et al. Japan Pain, Palliative Medicine, Rehabilitation, and Psycho-Oncology Study Group: Ethical validity of palliative sedation therapy: a multicenter, prospective, observational study conducted on specialized palliative care units in Japan. J Pain Symptom Manage 2005, 30:308-319.

233. Morita T, Tsunoda J, Inoue S et al. Communication Capacity Scale and Agitation Distress Scale to measure the severity of delirium in terminally ill cancer patients: a validation study. Palliat Med 2001, 15:197-206.

234. Morita T, Chinone Y, Ikenaga M et al. Japan Pain, Palliative Medicine, Rehabilitation, and Psycho-Oncology Study Group: Efficacy and safety of palliative sedation therapy: a multicenter, prospective, observational study conducted on specialized palliative care units in Japan. J Pain Symptom Manage 2005, 30:320-328.

235. Morita T, Ichiki T, Tsunoda J et al. A prospective study on the dying process in terminally ill cancer patients. Am J Hosp Palliat Care 1998, 15:217-222.

236. Morita T, Tei Y, Tsunoda J et al. Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. J Pain Symptom Manage 2001, 22:997-1006.

237. Morita T, Tei Y, Tsunoda J et al. Increased plasma morphine metabolites in terminally ill cancer patients with delirium: an intra-individual comparison. J Pain Symptom Manage 2002, 23:107-113.

238. Morita T, Tei Y, Tsunoda J et al. Determinants of the sensation of thirst in terminally ill cancer patients. Support Care Cancer 2001, 9:177-186.

239. Morita T, Tsunoda J, Inoue S et al. Contributing factors to physical symptoms in terminally-ill cancer patients. J Pain Symptom Manage 1999, 18:338-346.

240. Morita T, Tsunoda J, Inoue S et al. Survival prediction of terminally ill cancer patients by clinical symptoms: development of a simple indicator. Jpn J Clin Oncol 1999, 29:156-159.

241. Morita T, Tsunoda J, Inoue S et al. Effects of high dose opioids and sedatives on survival in terminally ill cancer patients. J Pain Symptom Manage 2001, 21:282-289.

242. Mustfa N, Walsh E, Bryant V et al. The effect of noninvasive ventilation on ALS patients and their caregivers. Neurology 2006, 66:1211-1217.

243. Nabal Vicuña M, Trujillano Cabello J, Ramírez Llarás M et al. Evaluación del dolor y del alivio del dolor mediante escalas visuales analógicas. [Pain assessment and pain relief assessment by visual analogue scales]. Sociedad Española de Cuidados Paliativos 2000, 7:81-84. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=187]

244. Nation R. Improving medication management of palliative care patients: Enhancing the role of community pharmacists (ongoing). CareSearch Project Research Studies Register [http://www.caresearch.com.au/home/Portals/CareSearch/Research%20Studies%20Register/0017.pdf]

245. Naudí Farré MC, Palomar Naval C, Nabal Vicuña M. Aportaciones de la evaluación de síntomas mediante escalas analógicas visuales en la relación enfermera-enfermo. [Contributions regarding symptom assessment by visual analogue scales in the relationship between nurses and patients]. Sociedad Española de Cuidados Paliativos 2004, 11:215-219. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=286]

246. Nekolaichuk CL, Bruera E, Spachynski K et al. A comparison of patient and proxy symptom assessments in advanced cancer patients. Palliat Med 1999, 13:311-323.

247. Neudert C, Oliver D, Wasner M et al. The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol 2001, 248:612-616.

248. Núñez Portela B, Martínez Cervantes Y, Hernández Calonge R et al. Diagnósticos enfermeros realizados por un ESAD en pacientes oncológicos en fase terminal. [Nursing diagnosis made in terminal cancer patients by a home support team]. Sociedad Española de Cuidados Paliativos 2005, 12:164-168. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=280]

249. O'Connor M. "What happens after dark?" Improving "after hours" palliative care planning in urban and rural Victoria. CareSearch Project Research Studies Register [http://www.caresearch.com.au/Home/Portals/CareSearch/Research%20Studies%20Register/0040.pdf]

250. O'Connor M. Dying in the Place of Choice: End of Life Care in Private Hospitals. CareSearch Project Research Studies Register [http://www.caresearch.com.au/Home/Portals/CareSearch/Research%20Studies%20Register/0039.pdf]

251. O'Connor M. Linking the parts: - Articulating the role of consultant Palliative Care Nurses in Acute Hospitals. CareSearch Project Research Studies Register

[http://www.caresearch.com.au/Home/Portals/CareSearch/Research%20Studies%20Register/0038.pdf]

252. O'Connor M. Survey of hospice and palliative care bereavement services in Australia. CareSearch Project Research Studies Register [http://www.caresearch.com.au/Home/Portals/CareSearch/Research%20Studies%20Register/0036.pdf]

253. Oltra Rodríguez E, Busto Toyos MªA, Cuevas Falagán MªJ et al. Úlceras de piel y pacientes en final de vida (Estudio comparativo con un grupo control de inmovilizados no terminales). [Skin ulcers and terminal patients (Comparative study with a group of non-terminal bed rest patients]. Sociedad Española de Cuidados Paliativos 2001, 8:120-125. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=44]

254. O'Mahony S, Goulet J, Kornblith A et al. Desire for hastened death, cancer pain and depression: report of a longitudinal observational study. J Pain Symptom Manage 2005, 29:446-457.

255. Oneschuk D, Fainsinger R, Demoissac D. Antibiotic use in the last week of life in three different palliative care settings. J Palliat Care 2002, 18:25-28.

256. Onsrud M, Hagen B, Strickert T. 10-Gy single-fraction pelvic irradiation for palliation and life prolongation in patients with cancer of the cervix and corpus uteri. Gynecol Oncol 2001, 82:167-171.

257. Orts Candela L, Fombuena Moreno M, Ferrer Pastor M. Cuidados Paliativos y rehabilitación. Experiencia en un hospital de media y larga estancia. [Palliative Care and rehabilitation. Experience in the hospice]. Sociedad Española de Cuidados Paliativos 2002, 9:116-119. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=217]

258. Oruezábal Moreno MJ, Burón Fernández MR. Trastornos psiquiátricos mayores en pacientes con cáncer. Estudio longitudinal prospective. [Major mental disorders in cancer patients. Prospective and longitudinal study]. Sociedad Española de Cuidados Paliativos 2004, 11:208-214. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=285]

259. Paci E, Miccinesi G, Toscani F et al. Quality of life assessment and outcome of palliative care. J Pain Symptom Manage 2001, 21:179-188.

260. Parsons SL, Lang MW, Steele RJ. Malignant ascites: a 2-year review from a teaching hospital. Eur J Surg Oncol 1996, 22:237-239.

261. Pereira J, Hanson J, Bruera E. The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer 1997, 79:835-842.

262. Pérez de Lucas N, López Martínez de Pinillos R, Sanz Juez JF et al. Opinión y utilización de la sedación terminal en el ámbito de la Atención Primaria. [Views and use of terminal sedation in primary health care]. Sociedad Española de Cuidados Paliativos 2004, 11:6-11. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=111]

263. Pérez Queiruga O, Solanes Cabús M, Nabal Vicuña M et al. Una alternativa al tratamiento con fentanilo: la morfina. [An alternative for the treatment with fentanyl: the morphine]. Sociedad Española de Cuidados Paliativos 2004, 11:17-19. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=109]

264. Phillips J. Residential - Palliative Approach Competency Study (R-PAC Study) CareSearch Project Research Studies Register [http://www.caresearch.com.au/home/Portals/CareSearch/Research%20Studies%20Register/0018.pdf]

265. Piller N. Objective assessment of the trajectory of the course of illness for end of life non-cancer related diseases - biological, social and environmental determinants (ongoing). CareSearch Project Research Studies Register [http://www.caresearch.com.au/home/Portals/CareSearch/Research%20Studies%20Register/0009.pdf]

266. Porta Sales J, Martínez García M, Gómez-Batiste X et al. Descripción de la complejidad de los pacientes en la consulta externa de un servicio de Cuidados Paliatiavos en un centro terciario: resultados preliminaries. [Description of the patient's complexity in the out-patient clinic in a Palliative Care Service: preliminary results]. Sociedad Española de Cuidados Paliativos 2003, 10:20-23. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=121]

267. Potter J, Hami F, Bryan T et al. Symptoms in 400 patients referred to palliative care services: prevalence and patterns. Palliat Med 2003, 17:310-314.

268. Potter J, Higginson IJ, Scadding JW et al. Identifying neuropathic pain in patients with head and neck cancer: use of the Leeds Assessment of Neuropathic Symptoms and Signs Scale. J R Soc Med 2003, 96:379-383.

269. Prada Jaimez MªL, Altuna Etxeberria E, Sánchez López E et al. Evaluación y tratamiento del estreñimiento en una unidad hospitalaria de Cuidados Paliativos. [Constipation evaluation and treatment in a hospital Palliative Care unit]. Sociedad Española de Cuidados Paliativos 200, 9:178-180. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=232]

270. Prigerson HG, Frank E, Kasl SV et al. Complicated grief and bereavement-related depression as distinct disorders: preliminary empirical validation in elderly bereaved spouses. Am J Psychiatry 1995, 152:22-30.

271. Prigerson HG, Bierhals AJ, Kasl SV et al. Complicated grief as a disorder distinct from bereavement-related depression and anxiety: a replication study. Am J Psychiatry 1996, 153:1484-1486.

272. Prigerson HG, Maciejewski PK, Reynolds CF 3rd et al. Inventory of Complicated Grief: a scale to measure maladaptive symptoms of loss. Psychiatry Res 1995, 59:65-79.

273. Prigerson HG. Socialization to dying: social determinants of death acknowledgement and treatment among terminally ill geriatric patients. J Health Soc Behav 1992, 33:378-395.

274. Quinsey K. Caring Communities: evaluation of a national palliative care program. CareSearch Project Research Studies Register [http://www.caresearch.com.au/Home/Portals/CareSearch/Research%20Studies%20Register/0028.pdf]

275. Quinsey K. Evaluation of the Care Planning Sub-program of the Local Palliative Care Grants Program. CareSearch Project Research Studies Register [http://www.caresearch.com.au/Home/Portals/CareSearch/Research%20Studies%20Register/0029.pdf]

276. Quinsey K. Evaluation of the Rural Palliative Care Program. CareSearch Project Research Studies Register

[http://www.caresearch.com.au/Home/Portals/CareSearch/Research%20Studies%20Register/0030.pdf]

277. Radbruch L, Sabatowski R, Loick G et al. Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine. Palliat Med 2000, 14:111-119.

278. Radbruch L, Loick G, Schulzeck S et al. Intravenous titration with morphine for severe cancer pain: report of 28 cases. Clin J Pain 1999, 15:173-178.

279. Rawlings D. Adelaide Hills palliative care project (National Rural Palliative Care Program) CareSearch Project Research Studies Register [http://www.caresearch.com.au/home/Portals/CareSearch/Research%20Studies%20Register/0012.pdf]

280. Ray A, Block SD, Friedlander RJ et al. Peaceful awareness in patients with advanced cancer. J Palliat Med 2006, 9:1359-1368.

281. Reuben DB, Mor V, Hiris J. Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med 1988, 148:1586-1591.

282. Rhee J. General Practitioners & Palliative Care Study (ongoing). CareSearch Project Research Studies Register [http://www.caresearch.com.au/Home/Portals/CareSearch/Research%20Studies%20Register/031.pdf]

283. Riaño Zalbidea V. Necesidades y recursos asistenciales hospitalarios del enfermo en situación terminal en la Comunidad Autónoma Vasca (CAV) en el año 2002. [Hospital necessities and welfare resources of the terminal ill patient in the Basque Country (CAV) in the year 2002]. Sociedad Española de Cuidados Paliativos 2004, 11:25-29. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=107]

284. Rihuete Galve MI, Santos Prieto L. Atención integral al paciente oncológico y su familia desde una intervención multidisciplinary. [Integral attention to oncology patients and their relatives from a multidisciplinary team]. Sociedad Española de Cuidados Paliativos 2005, 12:12-16. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=258]

285. Rogers A, Addington-Hall JM, McCoy AS et al. A qualitative study of chronic heart failure patients' understanding of their symptoms and drug therapy. Eur J Heart Fail 2002, 4:283-287.

286. Rogers A, Karlsen S, Addington-Hall J. 'All the services were excellent. It is when the human element comes in that things go wrong': dissatisfaction with hospital care in the last year of life. J Adv Nurs 2000, 31:768-774.

287. Romero C, Álvarez M, Bayés R et al. ¿Cuándo se pide la intervención del psicólogo en una unidad de cuidados paliativos? [When is the psychologist intervention required in a palliative care unit?]. Sociedad Española de Cuidados Paliativos 2001, 8:170-172. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=58]

288. Rose KE, Taylor HM, Twycross RG. Longterm compliance with treatment in obstructive arm lymphoedema in cancer. Palliat Med 1991, 5:52-55.

289. Rosenberg J. A study of the integration of health promotion principles and practice in palliative care organisations. CareSearch Project Research Studies Register [http://www.caresearch.com.au/home/Portals/CareSearch/Research%20Studies%20Register/0013.pdf]

290. Russell C, White K, Tan, J-Y. Palliative Nursing in Residential Aged Care (ongoing). CareSearch Project Research Studies Register [http://www.caresearch.com.au/home/Portals/CareSearch/Research%20Studies%20Register/0006.pdf]

291. Schumacher DL, Saclarides TJ, Staren ED. Peritoneovenous shunts for palliation of the patient with malignant ascites. Ann Surg Oncol 1994, 1:378-381.

292. Scott AG, Austin HE. Nasogastric feeding in the management of severe dysphagia in motor neurone disease. Palliat Med 1994, 8:45-49.

293. Sela RA, Bruera E, Conner-spady B et al. Sensory and affective dimensions of advanced cancer pain. Psychooncology 2002, 11:23-34.

294. Serrano F, Avellana JA, Barrero C et al. Control de síntomas en pacientes neoplásicos terminales atendidos por una unidad geriátrica de ayuda a domicilio. [Symptoms control in oncologic patients on home care geriatric unit]. Sociedad Española de Cuidados Paliativos

1999, 6:99-103. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=171]

295. Shipman C, Addington-Hall J, Barclay S et al. Educational opportunities in palliative care: what do general practitioners want? Palliat Med 2001, 15:191-196.

296. Shipman C, Addington-Hall J, Barclay S et al. How and why do GPs use specialist palliative care services? Palliat Med 2002, 16:241-246.

297. Shipman C, Addington-Hall J, Thompson M et al. Building bridges in palliative care: evaluating a GP Facilitator programme. Palliat Med 2003, 17:621-627.

298. Shipman C, Addington-Hall J, Richardson A et al. Palliative care services in England: a survey of district nurses' views. Br J Community Nurs 2005, 10:381-386.

299. Shivshanker K, Bennett RW Jr, Haynie TP. Tumor-associated gastroparesis: correction with metoclopramide. Am J Surg 1983, 145:221-225.

300. Singhvi R, Abbasakoor F, Manson JM. Insertion of self-expanding metal stents for malignant dysphagia: assessment of a simple endoscopic method. Ann R Coll Surg Engl 2000, 82:243-248.

301. Sladek R. Palliative care search strategy validation (ongoing). CareSearch Project Research Studies Register [http://www.caresearch.com.au/home/Portals/CareSearch/Research%20Studies%20Register/0001.pdf]

302. Spruyt O. An international multi-centre validation study of a pain classification system for advanced cancer pain. CareSearch Project Research Studies Register [http://www.caresearch.com.au/home/Portals/CareSearch/Research%20Studies%20Register/0014.pdf]

303. Spruyt O. Assessing the Impact of 'Catastrophizing' on the Measurement of Pain Intensity in Cancer Patients. CareSearch Project Research Studies Register [http://www.caresearch.com.au/home/Portals/CareSearch/Research%20Studies%20Register/0027.pdf]

304. Stirling LC, Kurowska A, Tookman A. The use of phenobarbitone in the management of agitation and seizures at the end of life. J Pain Symptom Manage 1999, 17:363-368.

305. Strömgren AS, Groenvold M, Pedersen L et al. Does the medical record cover the symptoms experienced by cancer patients receiving palliative care? A comparison of the record and patient self-rating. J Pain Symptom Manage 2001, 21:189-196.

306. Sweeney MP, Bagg J, Baxter WP et al. Oral disease in terminally ill cancer patients with xerostomia. Oral Oncol 1998, 34:123-126.

307. Sykes NP, Baines M, Carter RL. Clinical and pathological study of dysphagia conservatively managed in patients with advanced malignant disease. Lancet 1988, 2:726-728.

308. Sykes NP. The relationship between opioid use and laxative use in terminally ill cancer patients. Palliat Med 1998, 12:375-382.

309. Tan HS. Use of high dose rate gammamed brachytherapy in the palliative treatment of gynaecological cancer. Ann Acad Med Singapore 1994, 23:231-234.

310. Tarakeshwar N, Vanderwerker LC, Paulk E et al. Religious coping is associated with the quality of life of patients with advanced cancer. J Palliat Med 2006, 9:646-657.

311. Telerman A, Gerard B, Van den Heule B et al. Gastrointestinal metastases from extra-abdominal tumors. Endoscopy 1985, 17:99-101.

312. Thomas VN, Saleem T, Abraham R. Barriers to effective uptake of cancer screening among Black and minority ethnic groups. Int J Palliat Nurs 2005, 11:562, 564-71.

313. Thorns A, Sykes N. Opioid use in last week of life and implications for end-of-life decision-making. Lancet 2000, 356:398-399.

314. Tieman J. Evaluation of GP webpages of the CareSearch website (ongoing). CareSearch Project Research Studies Register http://www.caresearch.com.au/Home/Portals/CareSearch/Research%20Studies%20Register/0041.pdf

315. Toscani F. Classification and staging of terminal cancer patients: rationale and objectives of a multicentre cohort prospective study and

methods used. The Italian Co-operative Research Group on Palliative Medicine. Support Care Cancer 1996, 4:56-60.

316. Townsend PW, Smalley SR, Cozad SC et al. Role of postoperative radiation therapy after stabilization of fractures caused by metastatic disease. Int J Radiat Oncol Biol Phys 1995, 31:43-49.

317. Traynor BJ, Alexander M, Corr B et al. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry 2003, 74:1258-1261.

318. Tuca A, Porta J, Porce JM et al. Eficacia de los antagonistas de la serotonina en las náuseas y vómitos no relacionados con quimioterapia antineoplásica y resistentes al tratamiento habitual. [Efficacy of the antagonist serotonin receptors in nausea and vomiting non related with antineoplasic chemotherapy and resistance to usual treatment]. Sociedad Española de Cuidados Paliativos 2000, 7:62-66. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=241]

319. Tuca A, Anguera A. Acetato de megestrol en pacientes con síndrome de caquexia-anorexia por neoplasia avanzada. [Megestrol Acetate in cachexia-anorexia syndrome due to advanced neoplasms]. Sociedad Española de Cuidados Paliativos 2005, 12:71-76. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=310]

320. Tuca Rodríguez A, Nabal Vicuña M, Porta Sales J et al. Estudio multicéntrico catalano-balear sobre la sedación terminal en Cuidados Paliativos. [Multi-center catalano-balear study about the terminal sedation in Palliative Care]. Sociedad Española de Cuidados Paliativos 1999, 6:153-158. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=185]

321. Turner NJ, Muers MF, Haward RA et al. Do elderly people with lung cancer benefit from palliative radiotherapy? Lung Cancer 2005, 49:193-202.

322. Twycross RG. Clinical experience with diamorphine in advanced malignant disease. Int J Clin Pharmacol 1974, 7:184-198.

323. Twycross RG, Harcourt JMV. The use of laxatives at a palliative care centre. Palliat Med 1991, 4:27-33.

324. Twycross RG, McNamara P, Schuijt C et al. Sodium picosulfate in opioid induced constipation; results of an open-label, prospective, dose-ranging study. Palliat Med 2006, 20:419-423.

325. Vanderwerker LC, Laff RE, Kadan-Lottick NS et al. Psychiatric disorders and mental health service use among caregivers of advanced cancer patients. J Clin Oncol 2005, 23:6899-6907.

326. Vejlgaard T, Addington-Hall JM. Attitudes of Danish doctors and nurses to palliative and terminal care. Palliat Med 2005, 19:119-127.

327. Vidal Sicart R, Guitart Vela J, Vázquez Ignacio JM et al. Tratamiento del dolor oncológico irruptivo con citrato de fentanilo transmucosa oral. [Treatment of breakthrough cancer pain with oral transmucosal fentanyl citrate]. Sociedad Española de Cuidados Paliativos 2005, 12:79-82. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=268]

328. Vigano A, Donaldson N, Higginson IJ et al. Quality of life and survival prediction in terminal cancer patients: a multicenter study. Cancer 2004, 101:1090-1098.

329. Vitetta L, Kenner D, Sali A et al. Bacterial infections in terminally ill hospice patients. J Pain Symptom Manage 2000, 20:326-334.

330. Voravud N, Sriuranpong V. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy. J Med Assoc Thai 2005, 88:607-612.

331. Walsh D, Donnelly S, Rybicki L. The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 2000, 8:175-179.

332. Wein S. An Audit of the Incidence, Mechanism, Aetiology and Management of Nausea and Vomiting in Patients at a Comprehensive Cancer Centre. CareSearch Project Research Studies Register [http://www.caresearch.com.au/home/Portals/CareSearch/Research%20Studies%20Register/0026.pdf]

333. Wenk R, Bertolino M, De Lima L. Analgésicos opioides en Latinoamérica: la barrera de accesibilidad supera la de disponibilidad. [Opioid analgesics in Latin America: the barrier of accesibility with low incomes]. Sociedad Española de Cuidados Paliativos 2004,

11:148-151. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=87]

334. Wenk R, Monti C, Bertolino M. Asistencia a distancia: ¿mejor o peor que nada? [Distance care: better or worse than nothing?]. Sociedad Española de Cuidados Paliativos 2003, 10:136-141. [http://www.secpal.com/medicina_paliativa/index.php?acc=verart&idart=146]

335. Wildiers H, Menten J. Death rattle: prevalence, prevention and treatment. J Pain Symptom Manage 2002, 23:310-317.

336. Williams J. Bayside Palliative Carers Support Group(ongoing). CareSearch Project Research Studies Register[http://www.caresearch.com.au/Home/Portals/CareSearch/Research%20Studies%20Register/0035.pdf]

337. Wilson J, Plourde JY, Marshall D et al. Long-term safety and clinical effectiveness of controlled-release metoclopramide in cancer-associated dyspepsia syndrome: a multicentre evaluation. J Palliat Care 2002, 18:84-91.

338. Wilson M. Caring for the dying other: Mapping the ethical dimension of Hospice Palliative Care Practice (ongoing). CareSearch Project Research Studies Register[http://www.caresearch.com.au/home/Portals/CareSearch/Research%20Studies%20Register/0020.pdf]

339. Zervos EE, McCormick J, Goode SE et al. Peritoneovenous shunts in patients with intractable ascites: palliation at what price? Am Surg 1997, 63:157-162.

340. Zivin Bambauer K, Zhang B, Maciejewski PK et al. Mutuality and specificity of mental disorders in advanced cancer patients and caregivers. Soc Psychiatry Psychiatr Epidemiol 2006, xx:1-7.